CReDO Science

CReDO Science is a private biotechnology company focused on the investigation and commercialization of the endocannabinoid system (ECS). Founded by renowned neurologist and cannabinoid researcher Dr. Ethan Russo, the company specializes in developing optimized botanical products and pharmaceutical formulations. Their work emphasizes the "entourage effect," utilizing combinations of cannabinoids and terpenoids to address complex conditions such as chronic pain and neurological disorders. CReDO Science provides research services, intellectual property licensing, and consulting to the broader cannabis and life sciences industries. The company also develops diagnostic tools like Cannevert, designed to assess cannabis impairment, and other assays to measure endocannabinoid tone. Through strategic partnerships, CReDO Science translates rigorous scientific research into accessible therapeutic products and educational resources.